Funding and Research Opportunities
The following research opportunity announcement from the NHLBI or other components of the National Institutes of Health, might be of interest:
Kids First Program Re-Issues Opportunity Announcement for Whole Genome Sequencing
The National Institutes of Health (NIH) invites applications (PAR-16-16-150) to identify samples for whole genome sequencing that will help to elucidate the genetic contribution to childhood cancers and the genetic etiology of structural birth defects. The NHLBI encourages investigators with sample collections directed toward heart, lung, blood or sleep-related congenital defects or pediatric cancers to apply. This opportunity is part of the NIH Common Fund’s Gabriella Miller Kids First Pediatric Research Program (Kids First). Successful applicants will receive sequencing services at no cost through a Kids First-supported sequencing center.
The genetic and clinical data will become part of the Gabriella Miller Kids First Pediatric Data Resource for the pediatric research community. This resource will allow scientists to identify genetic pathways that underlie childhood cancer and structural birth defects and to explore whether shared genetic pathways exist between childhood cancer and structural birth defects.
Read the FAQs
Letters of Intent: Due May 17, 2016
Applications: Due June 17, 2016
The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.
The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about the NIH and its programs, visit the NIH website.
The genetic and clinical data will become part of the Gabriella Miller Kids First Pediatric Data Resource for the pediatric research community. This resource will allow scientists to identify genetic pathways that underlie childhood cancer and structural birth defects and to explore whether shared genetic pathways exist between childhood cancer and structural birth defects.
Read the FAQs
Letters of Intent: Due May 17, 2016
Applications: Due June 17, 2016
The NIH Common Fund (formerly the NIH Roadmap) encourages collaboration and supports a series of exceptionally high impact, trans-NIH programs. These programs are supported by the Common Fund, and managed by the NIH Office of the Director in partnership with the various NIH Institutes, Centers, and Offices.
The National Institutes of Health (NIH) –“The Nation's Medical Research Agency” – includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about the NIH and its programs, visit the NIH website.
.png)
No hay comentarios:
Publicar un comentario